Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026)
Zai Lab (ZLAB) posted quarterly Other Accumulated Expenses of $47.0 million for Q1 2026, up 27.71% year-on-year from $36.8 million in Q1 2025, and down 26.18% on a QoQ basis from $63.7 million in Q4 2025.
Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Other Accumulated Expenses for 11 consecutive years, with $47.0 million the latest figure, recorded in Q1 2026.
- Quarterly Other Accumulated Expenses rose 27.71% year-over-year to $47.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.0 million (up 27.71% YoY) and the FY2025 annual result came in at $63.7 million, up 8.45% from the prior year.
- Other Accumulated Expenses slipped to $47.0 million in Q1 2026 per ZLAB's latest filing, from $63.7 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for ZLAB reached as high as $83.0 million in Q4 2023 and fell as low as $36.8 million in Q1 2025.
- A 5-year average of $54.5 million and a median of $51.5 million in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses fell 29.23% — and 2026, when it climbed 27.71%.
- Year by year, Other Accumulated Expenses stood at $66.8 million in 2022, then climbed by 24.18% to $83.0 million in 2023, then decreased by 29.23% to $58.7 million in 2024, then grew by 8.45% to $63.7 million in 2025, then retreated by 26.18% to $47.0 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $47.0 million, $63.7 million, and $51.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Zai Lab | 20.66 Bn | 19.91 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.01 Mn |
| Dec 31, 2025 | 63.68 Mn |
| Sep 30, 2025 | 51.54 Mn |
| Jun 30, 2025 | 44.05 Mn |
| Mar 31, 2025 | 36.81 Mn |
| Dec 31, 2024 | 58.72 Mn |
| Sep 30, 2024 | 46.08 Mn |
| Jun 30, 2024 | 46.50 Mn |
| Mar 31, 2024 | 48.18 Mn |
| Dec 31, 2023 | 82.97 Mn |
| Sep 30, 2023 | 62.99 Mn |
| Jun 30, 2023 | 59.02 Mn |
| Mar 31, 2023 | 50.88 Mn |
| Dec 31, 2022 | 66.82 Mn |
| Sep 30, 2022 | 58.46 Mn |
| Jun 30, 2022 | 53.61 Mn |
| Mar 31, 2022 | 49.96 Mn |
| Dec 31, 2021 | 60.81 Mn |
| Sep 30, 2021 | 54.29 Mn |
| Jun 30, 2021 | 61.93 Mn |